NFKB1 and prostate carcinoma: Inhibitory effects of PL on NF-κB activity have been reported in several studies on atherosclerotic plaque formation, Burkitt lymphoma, and prostate cancer cells (Son et al. 2012; Han et al. 2013; Ginzburg et al. 2014).